Diligence memo · auto-generated · as of July 2, 2026
PROCEPT BioRobotics Corp
PROCEPT BioRobotics Corp looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
PROCEPT BioRobotics Corp operates in Other Health Care, based in Redwood City.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
PROCEPT BioRobotics Corp has raised $349M in disclosed capital across 7 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).
Largest single filing: $118M on 2018-02-15.
Most recent recorded round closed around 2021-06-10.
Valuation (modeled)modeled
Provath models PROCEPT BioRobotics Corp at approximately $1.6B (range $453M–$3.2B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.49× the median modeled value of Series D+ Other Health Care companies in 2019–2021 (26 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 13 months.
Last raise 5.1 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.1× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 99% of Other Health Care peers (5377 compared).
Modeled value ranks above 98% of those peers.
Closest niche peers: ZAHN Parent, LLC, Covetrus, Inc., EQH Parent, LLC, SonerMed, LLC, Fs Usme Lp.
Peoplefiled
20 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.